81209

Gene analysis (bloom syndrome, recq helicase-like)

Medicare pricing data for 69 providers across 9 states

🤖AI Overview

Note: These costs reflect the Medicare physician/supplier component. Hospital facility fees are billed separately and can be 2-5x the physician fee.

💡 What You Should Know

Gene analysis (bloom syndrome, recq helicase-like) (HCPCS code 81209) is a medical procedure billed to Medicare. The average Medicare-allowed cost is $38.51, but hospitals typically charge $43.92 — a 1.1x markup. Prices vary significantly by state and provider.

🏷️ Typical Out-of-Pocket Cost

$7.70

Medicare patients typically pay about 20% of the allowed amount as coinsurance. Based on the average allowed cost of $38.51, your out-of-pocket cost would be approximately $7.70. Actual costs depend on your specific plan, deductible, and whether you've met your annual out-of-pocket maximum.

Average Allowed Cost
$38.51
Average Hospital Charge
$43.92
Markup Ratio
1.1x

What Hospitals Charge vs. What Medicare Pays

Hospital Charge$43.92
Medicare Allowed$38.51
Medicare Payment$38.51

Hospitals charge 1.1x more than what Medicare allows for this procedure. Medicare actually pays $38.51 on average.

Cost by State

Medicare-allowed amounts vary significantly by state

StateAllowed CostHospital ChargeProvidersServicesvs. National
Louisiana$39$582119+0.0%
Mississippi$39$118111+0.0%
Oklahoma$39$43299+0.0%
Pennsylvania$39$3924,151+0.0%
Arizona$39$50160+0.0%
Colorado$39$161287+0.0%
Florida$39$432416,7280.0%
New Jersey$39$4586,2870.0%
Texas$39$45248,721-0.0%

⚠️ Important: These costs reflect the Medicare physician/supplier component. Hospital facility fees may be billed separately. Total out-of-pocket costs may be higher.

Related from TheDataProject.ai

💊 Need post-procedure medications? Check costs on OpenPrescriber